Hypomyelination Leukodystrophy Type 11 (HLD11) Presenting with Diabetes: A Case Report and Literature Review

Hypomyelination leukodystrophies (HLDs) are a group of rare genetic disorders that impair myelin formation in the central nervous system (CNS), leading to developmental delays and neurological symptoms. HLD type 11 (HLD11) is caused by mutations in the POLR1C gene, manifesting with a 4H phenotype (hypomyelination, hypodontia, and hypogonadotropic hypogonadism) and associated neurodevelopmental delays. Here, we report a case of a male patient diagnosed with HLD11 who presented with developmental delay, hypotonia, and cerebellar atrophy. Whole exome sequencing identified a homozygous likely pathogenic POLR1C variant. Notably, the patient developed diabetes, an association not previously documented in HLD11. Despite intensive care, he ultimately passed away due to complications at 3.5 years of age. This report highlights the importance of thorough endocrinological evaluation in HLD patients and underscores the need for further research to understand the full spectrum of HLD11 manifestations.

Authors

Institutions

Publication Details

Journal
Sage Open Pediatrics
Published
2025-02-01
DOI
https://doi.org/10.1177/30502225251311135
Primary Topic
RNA regulation and disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypomyelination Leukodystrophy Type 11 (HLD11) Presenting with Diabetes: A Case Report and Literature Review

Qusai A Alsalah, Mohammad I. Smerat, Lina Y. Alqam, Ramzi H. Mujahed et al.
Sage Open Pediatrics
RNA regulation and disease
article

Hypomyelination Leukodystrophy Type 11 (HLD11) Presenting with Diabetes: A Case Report and Literature Review

Qusai A Alsalah, Mohammad I. Smerat, Lina Y. Alqam, Ramzi H. Mujahed, Donya Y. Alqam, Kawthar S. Jarrar, Yasmin A. Rjob
article en

Abstract

Hypomyelination leukodystrophies (HLDs) are a group of rare genetic disorders that impair myelin formation in the central nervous system (CNS), leading to developmental delays and neurological symptoms. HLD type 11 (HLD11) is caused by mutations in the POLR1C gene, manifesting with a 4H phenotype (hypomyelination, hypodontia, and hypogonadotropic hypogonadism) and associated neurodevelopmental delays. Here, we report a case of a male patient diagnosed with HLD11 who presented with developmental delay, hypotonia, and cerebellar atrophy. Whole exome sequencing identified a homozygous likely pathogenic POLR1C variant. Notably, the patient developed diabetes, an association not previously documented in HLD11. Despite intensive care, he ultimately passed away due to complications at 3.5 years of age. This report highlights the importance of thorough endocrinological evaluation in HLD patients and underscores the need for further research to understand the full spectrum of HLD11 manifestations.

Sage Open PediatricsVol. 12
Hebron University (PS), Palestine Polytechnic University (PS), Al-Ahli Hospital (QA)
Good health and well-being
Openalex Percentile: Top 97%
RNA regulation and disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.